These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12627035)

  • 1. Does oral contraceptive use lead to hormone therapy use in women doctors? Our bodies, our choices, our practice.
    Santoro NF
    Menopause; 2003; 10(2):109-10. PubMed ID: 12627035
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and personal relationships between oral contraceptive and hormone replacement therapy use among US women physicians.
    Frank E; Elon L
    Menopause; 2003; 10(2):133-41. PubMed ID: 12627038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women doctors' use of hormone replacement therapy. High prevalence of use is not confined to doctors.
    Banks E; Crossley B; English R; Richardson A
    BMJ; 1996 Mar; 312(7031):638. PubMed ID: 8595357
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies.
    Schwartz AG; Ray RM; Cote ML; Abrams J; Sokol RJ; Hendrix SL; Chen C; Chlebowski RT; Hubbell FA; Kooperberg C; Manson JE; O'Sullivan MJ; Rohan T; Stefanick ML; Wactawski-Wende J; Wakelee H; Simon MS
    J Thorac Oncol; 2015 Jul; 10(7):1004-13. PubMed ID: 25852020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study.
    Barad D; Kooperberg C; Wactawski-Wende J; Liu J; Hendrix SL; Watts NB
    Fertil Steril; 2005 Aug; 84(2):374-83. PubMed ID: 16084878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helping women achieve long-term continuance of estrogen replacement therapy (ERT) and hormone replacement therapy (HRT).
    Keenan NL; Anderson LA; LaCroix AZ; Newton KM; Buist DS
    Menopause; 1999; 6(2):179-80. PubMed ID: 10374227
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement therapy and previous use of oral contraceptives among Swedish women.
    Hammar M; Brynhildsen J; Dabrosin L; Frisk J; Lindgren R; Nedstrand E; Wyon Y
    Maturitas; 1996 Nov; 25(3):193-9. PubMed ID: 8981336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's Health Initiative reverses its findings on coronary heart disease.
    Brown S
    Menopause Int; 2007 Jun; 13(2):52-3. PubMed ID: 17802648
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical problems which women encounter with available contraception in Australia.
    Weisberg E
    Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):312-5. PubMed ID: 7848207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilisation of hormone replacement therapy by women doctors.
    Isaacs AJ; Britton AR; McPherson K
    BMJ; 1995 Nov; 311(7017):1399-401. PubMed ID: 8520274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.
    McNagny SE; Wenger NK; Frank E
    Ann Intern Med; 1997 Dec; 127(12):1093-6. PubMed ID: 9412312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How WHI study influences women doctors' behavior toward menopause. Gynecol Obstet Fertil 2006;34:499-505].
    Trémollières F
    Gynecol Obstet Fertil; 2006 Oct; 34(10):996-8. PubMed ID: 16978901
    [No Abstract]   [Full Text] [Related]  

  • 15. More controversy over breast cancer rates in the USA.
    Brown S
    Menopause Int; 2007 Jun; 13(2):51-2. PubMed ID: 17802647
    [No Abstract]   [Full Text] [Related]  

  • 16. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Merz CN; Johnson BD; Berga S; Braunstein G; Reis SE; Bittner V;
    Fertil Steril; 2006 May; 85(5):1425-31. PubMed ID: 16600235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
    Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
    Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 19. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
    Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
    J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project.
    Lundberg V; Tolonen H; Stegmayr B; Kuulasmaa K; Asplund K;
    Maturitas; 2004 May; 48(1):39-49. PubMed ID: 15223107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.